ArticleClinical and translational medicine2025

The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers.

Ronan J Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.